Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Non-Current Debt (2020 - 2025)

iBio (IBIO) has disclosed Non-Current Debt for 6 consecutive years, with $64000.0 as the latest value for Q2 2025.

  • On a quarterly basis, Non-Current Debt fell 91.64% to $64000.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $64000.0, a 91.64% decrease, with the full-year FY2025 number at $64000.0, down 91.64% from a year prior.
  • Non-Current Debt was $64000.0 for Q2 2025 at iBio, down from $643000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $22.1 million in Q1 2022 to a low of $34000.0 in Q1 2021.
  • A 5-year average of $5.8 million and a median of $674500.0 in 2024 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: skyrocketed 64958.82% in 2022, then crashed 91.64% in 2025.
  • iBio's Non-Current Debt stood at $22.1 million in 2021, then increased by 0.3% to $22.1 million in 2022, then tumbled by 98.91% to $241000.0 in 2023, then skyrocketed by 166.8% to $643000.0 in 2024, then crashed by 90.05% to $64000.0 in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Non-Current Debt are $64000.0 (Q2 2025), $643000.0 (Q4 2024), and $706000.0 (Q3 2024).